OBJECTS: Hepatic and pancreatic fat content become increasingly important for phenotyping of individuals with metabolic diseases. This study aimed to (1) evaluate hepatic fat fractions (HFF) and pancreatic fat fractions (PFF) using (1)H magnetic resonance spectroscopy (MRS) and the recently introduced fast mDixon method, and to examine body fat effects on HFF and PFF, (2) investigate regional differences in HFF and PFF by mDixon. MATERIALS AND METHODS: HFF and PFF were quantified by mDixon with two flexible echo times and by single voxel (1)H MRS in 24 healthy subjects. The regional differences of PFF within the pancreas were assessed with mDixon. Abdominal visceral and subcutaneous fat was assessed by T1-weighted MRI at 3T. RESULTS: Both methods correlated well for quantification of HFF (r = 0.98, p < 0.0001) and PFF (r = 0.80, p < 0.0001). However, mDixon showed a higher low limit in HFF and PFF. PFF showed no regional differences using mDixon. In addition, both visceral and subcutaneous fat correlated with pancreatic fat, while only visceral fat correlated with liver fat, employing both (1)H MRS and mDixon. CONCLUSION: The novel and fast two-point mDixon exhibits a good correlation with the gold-standard (1)H MRS for assessment of HFF and PFF, with limited sensitivity for assessing lower fat content.
OBJECTS: Hepatic and pancreatic fat content become increasingly important for phenotyping of individuals with metabolic diseases. This study aimed to (1) evaluate hepatic fat fractions (HFF) and pancreatic fat fractions (PFF) using (1)H magnetic resonance spectroscopy (MRS) and the recently introduced fast mDixon method, and to examine body fat effects on HFF and PFF, (2) investigate regional differences in HFF and PFF by mDixon. MATERIALS AND METHODS: HFF and PFF were quantified by mDixon with two flexible echo times and by single voxel (1)H MRS in 24 healthy subjects. The regional differences of PFF within the pancreas were assessed with mDixon. Abdominal visceral and subcutaneous fat was assessed by T1-weighted MRI at 3T. RESULTS: Both methods correlated well for quantification of HFF (r = 0.98, p < 0.0001) and PFF (r = 0.80, p < 0.0001). However, mDixon showed a higher low limit in HFF and PFF. PFF showed no regional differences using mDixon. In addition, both visceral and subcutaneous fat correlated with pancreatic fat, while only visceral fat correlated with liver fat, employing both (1)H MRS and mDixon. CONCLUSION: The novel and fast two-point mDixon exhibits a good correlation with the gold-standard (1)H MRS for assessment of HFF and PFF, with limited sensitivity for assessing lower fat content.
Authors: N J van der Zijl; G H Goossens; C C M Moors; D H van Raalte; M H A Muskiet; P J W Pouwels; E E Blaak; M Diamant Journal: J Clin Endocrinol Metab Date: 2010-11-17 Impact factor: 5.958
Authors: Ildiko Lingvay; Victoria Esser; Jaime L Legendre; Angela L Price; Kristen M Wertz; Beverley Adams-Huet; Song Zhang; Roger H Unger; Lidia S Szczepaniak Journal: J Clin Endocrinol Metab Date: 2009-09-22 Impact factor: 5.958
Authors: Kim-Anne Lê; Emily E Ventura; Jessica Q Fisher; Jaimie N Davis; Marc J Weigensberg; Mark Punyanitya; Houchun H Hu; Krishna S Nayak; Michael I Goran Journal: Diabetes Care Date: 2011-02 Impact factor: 19.112
Authors: Cheng William Hong; Soudabeh Fazeli Dehkordy; Jonathan C Hooker; Gavin Hamilton; Claude B Sirlin Journal: Top Magn Reson Imaging Date: 2017-12
Authors: Paul Begovatz; Chrysi Koliaki; Katharina Weber; Klaus Strassburger; Bettina Nowotny; Peter Nowotny; Karsten Müssig; Jürgen Bunke; Giovanni Pacini; Julia Szendrödi; Michael Roden Journal: Diabetologia Date: 2015-03-05 Impact factor: 10.122
Authors: Julia Szendroedi; Aaruni Saxena; Katharina S Weber; Klaus Strassburger; Christian Herder; Volker Burkart; Bettina Nowotny; Andrea Icks; Oliver Kuss; Dan Ziegler; Hadi Al-Hasani; Karsten Müssig; Michael Roden Journal: Cardiovasc Diabetol Date: 2016-04-07 Impact factor: 9.951